Team
Jordan S. Davis
Managing Partner
Jordan S. Davis is a Managing Partner and co-founder of Radius, which acts as the Investment Advisor to the Radius Funds. Jordan’s experience spans the founding of new ventures to growth capital stage investing in a broad range of innovative healthcare, medical technology and life sciences companies. The most critical part of Jordan's job is to add value to the Radius portfolio companies, providing judgment, deal-making expertise and C-Level access to firm’s deep and vast network of industry relationships that have often proven to result in "game-changing" opportunities.

Having begun his career at Morgan Stanley & Co., Jordan brings capital markets expertise and perspective to Radius’ portfolio companies as they navigate an increasingly complex and challenging financing environment. Prior to Radius, Jordan was a Managing Director at KBL Healthcare, Inc., a venture capital and investment banking firm, where he co-founded and served as Vice President and board member of KBL Healthcare Acquisition Corp. (KBL), a publicly traded acquisition vehicle designed to provide an alternative means for an emerging private healthcare company to access vital growth capital. KBL successfully merged with Concord Health Group, a rapidly growing long-term care provider, where Jordan continued to serve as a board member until its ultimate acquisition by The Multicare Companies.

As an entrepreneur, Jordan was a founder of Cambridge Heart, Inc., a cardiology device company that developed and commercialized breakthrough technology to non-invasively diagnose patients at risk of sudden cardiac death, and Voxware, Inc., a speech technology company and early entrant into the voice over IP market; both of these companies moved from start-up to IPO in three years.

Jordan brings his expertise, entrepreneurial creativity, vision and passion to the Radius portfolio companies, having led investments in companies including BioStorage Technologies (acquired by Brooks Automation), BEI Medical Systems (acquired by Boston Scientific), Conor Medsystems (acquired by J&J), Medingo (acquired by Roche) and Health Language (acquired by Wolters Kluwer).

He has served on numerous public and private company boards and currently serves on the board of directors of Athersys, Inc. (Nasdaq: ATHX), a leading regenerative medicine company developing "off-the-shelf" stem cell therapeutics, Endogastric Solutions, a leading medical technology company enabling the incisionless treatment of acid reflux disease, and Tactile Medical (Nasdaq: TCMD), a leading medical technology company enabling “at home” treatment alternatives for chronic swelling and venous leg ulcers. Jordan also serves on the board of directors of HealthCorps, a national non-profit peer mentoring organization dedicated to fighting childhood obesity through educating and empowering youth to take charge of their health.

Jordan earned an M.B.A. from the Kellogg School of Management at Northwestern University and a B.A. in Economics from The State University of New York at Binghamton.